| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Central Nervous System Vascular Malformations | 56 | 2025 | 75 | 18.840 |
Why?
|
| Embolization, Therapeutic | 87 | 2025 | 323 | 16.190 |
Why?
|
| Intracranial Aneurysm | 87 | 2025 | 370 | 15.840 |
Why?
|
| Intracranial Arteriovenous Malformations | 55 | 2025 | 80 | 13.650 |
Why?
|
| Endovascular Procedures | 66 | 2025 | 624 | 11.360 |
Why?
|
| Cerebral Angiography | 95 | 2025 | 294 | 11.270 |
Why?
|
| Magnetic Resonance Imaging | 152 | 2025 | 2188 | 10.020 |
Why?
|
| Stents | 40 | 2025 | 498 | 5.570 |
Why?
|
| Magnetic Resonance Angiography | 37 | 2021 | 186 | 5.300 |
Why?
|
| Arteriovenous Fistula | 23 | 2022 | 41 | 4.920 |
Why?
|
| Cerebral Veins | 22 | 2023 | 36 | 4.810 |
Why?
|
| Tomography, X-Ray Computed | 58 | 2025 | 1648 | 4.300 |
Why?
|
| Spinal Cord | 30 | 2025 | 205 | 4.200 |
Why?
|
| Aneurysm, Ruptured | 17 | 2025 | 76 | 4.200 |
Why?
|
| Stroke | 36 | 2025 | 1189 | 4.190 |
Why?
|
| Humans | 436 | 2025 | 63587 | 4.180 |
Why?
|
| Thrombectomy | 20 | 2025 | 240 | 4.170 |
Why?
|
| Brain | 55 | 2025 | 1556 | 4.040 |
Why?
|
| Middle Aged | 204 | 2025 | 17682 | 3.750 |
Why?
|
| Male | 265 | 2025 | 29967 | 3.630 |
Why?
|
| Female | 270 | 2025 | 32979 | 3.510 |
Why?
|
| Retrospective Studies | 106 | 2025 | 6646 | 3.440 |
Why?
|
| Treatment Outcome | 115 | 2025 | 5669 | 3.420 |
Why?
|
| Subarachnoid Hemorrhage | 22 | 2025 | 108 | 3.360 |
Why?
|
| Adult | 190 | 2025 | 16904 | 3.320 |
Why?
|
| Cerebrovascular Circulation | 22 | 2021 | 181 | 3.220 |
Why?
|
| Postoperative Complications | 17 | 2025 | 1290 | 3.160 |
Why?
|
| Angiography, Digital Subtraction | 37 | 2024 | 135 | 3.100 |
Why?
|
| Radiosurgery | 11 | 2022 | 69 | 3.100 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 14 | 2024 | 20 | 3.080 |
Why?
|
| Aged | 148 | 2025 | 14481 | 3.050 |
Why?
|
| Brain Neoplasms | 30 | 2021 | 311 | 2.950 |
Why?
|
| Arteriovenous Malformations | 17 | 2025 | 44 | 2.910 |
Why?
|
| Brain Ischemia | 26 | 2022 | 421 | 2.720 |
Why?
|
| Dura Mater | 16 | 2023 | 33 | 2.700 |
Why?
|
| Neuroimaging | 15 | 2023 | 153 | 2.630 |
Why?
|
| Cerebral Arteries | 14 | 2020 | 40 | 2.460 |
Why?
|
| Superior Sagittal Sinus | 3 | 2025 | 3 | 2.320 |
Why?
|
| Brain Diseases | 10 | 2020 | 78 | 2.250 |
Why?
|
| Neurosurgical Procedures | 23 | 2024 | 99 | 2.130 |
Why?
|
| Cerebrovascular Disorders | 8 | 2020 | 81 | 2.060 |
Why?
|
| Carotid Artery, Internal | 13 | 2021 | 68 | 2.050 |
Why?
|
| Imaging, Three-Dimensional | 14 | 2025 | 286 | 1.950 |
Why?
|
| Aneurysm | 10 | 2020 | 60 | 1.940 |
Why?
|
| Spine | 8 | 2019 | 49 | 1.810 |
Why?
|
| Vein of Galen Malformations | 7 | 2025 | 7 | 1.780 |
Why?
|
| Carotid Artery Diseases | 10 | 2025 | 63 | 1.770 |
Why?
|
| Cerebral Hemorrhage | 9 | 2021 | 98 | 1.720 |
Why?
|
| Spinal Cord Diseases | 7 | 2014 | 41 | 1.700 |
Why?
|
| Motor Cortex | 20 | 2010 | 71 | 1.690 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 5 | 2024 | 6 | 1.680 |
Why?
|
| Brain Mapping | 25 | 2009 | 232 | 1.650 |
Why?
|
| Meningeal Neoplasms | 6 | 2023 | 59 | 1.630 |
Why?
|
| Intracranial Arteriosclerosis | 4 | 2023 | 47 | 1.590 |
Why?
|
| Carotid Stenosis | 5 | 2019 | 100 | 1.560 |
Why?
|
| Image Enhancement | 12 | 2021 | 193 | 1.540 |
Why?
|
| Cavernous Sinus | 5 | 2025 | 8 | 1.470 |
Why?
|
| Seizures | 9 | 2019 | 143 | 1.460 |
Why?
|
| Meningeal Arteries | 4 | 2021 | 10 | 1.430 |
Why?
|
| Middle Cerebral Artery | 7 | 2019 | 50 | 1.410 |
Why?
|
| Epilepsy | 6 | 2023 | 111 | 1.350 |
Why?
|
| Child | 52 | 2025 | 4541 | 1.310 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 11 | 2013 | 154 | 1.310 |
Why?
|
| Cervical Vertebrae | 8 | 2023 | 115 | 1.300 |
Why?
|
| Meningioma | 7 | 2016 | 60 | 1.300 |
Why?
|
| Contrast Media | 13 | 2020 | 427 | 1.300 |
Why?
|
| Image Processing, Computer-Assisted | 23 | 2021 | 659 | 1.280 |
Why?
|
| Young Adult | 37 | 2025 | 4716 | 1.250 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 4 | 2018 | 8 | 1.230 |
Why?
|
| Polymicrogyria | 2 | 2019 | 3 | 1.230 |
Why?
|
| Follow-Up Studies | 39 | 2025 | 2467 | 1.190 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 208 | 1.190 |
Why?
|
| Headache | 6 | 2025 | 58 | 1.180 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 222 | 1.180 |
Why?
|
| Adolescent | 54 | 2025 | 6260 | 1.170 |
Why?
|
| Self Expandable Metallic Stents | 6 | 2020 | 33 | 1.150 |
Why?
|
| Basilar Artery | 6 | 2023 | 32 | 1.150 |
Why?
|
| Thrombolytic Therapy | 7 | 2020 | 193 | 1.130 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 7 | 2019 | 72 | 1.130 |
Why?
|
| Cerebral Cortex | 11 | 2023 | 263 | 1.100 |
Why?
|
| Aged, 80 and over | 44 | 2024 | 5483 | 1.090 |
Why?
|
| Infant | 32 | 2024 | 1654 | 1.090 |
Why?
|
| Pyramidal Tracts | 10 | 2006 | 25 | 1.080 |
Why?
|
| Child, Preschool | 33 | 2025 | 1999 | 1.070 |
Why?
|
| Vascular Malformations | 3 | 2023 | 22 | 1.050 |
Why?
|
| Blood Vessel Prosthesis | 11 | 2020 | 219 | 1.050 |
Why?
|
| Veins | 7 | 2021 | 64 | 1.040 |
Why?
|
| Blood Vessels | 2 | 2021 | 63 | 1.030 |
Why?
|
| Vertebral Artery | 8 | 2020 | 28 | 1.020 |
Why?
|
| Intracranial Hemorrhages | 5 | 2021 | 68 | 1.010 |
Why?
|
| Brain Edema | 4 | 2021 | 30 | 0.990 |
Why?
|
| Femoral Artery | 2 | 2024 | 106 | 0.980 |
Why?
|
| Perfusion Imaging | 7 | 2019 | 20 | 0.970 |
Why?
|
| Angioplasty, Balloon | 4 | 2019 | 58 | 0.960 |
Why?
|
| Intracranial Embolism | 4 | 2019 | 39 | 0.950 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2025 | 18 | 0.920 |
Why?
|
| Hemorrhage | 4 | 2020 | 267 | 0.900 |
Why?
|
| Central Nervous System Neoplasms | 3 | 2015 | 39 | 0.900 |
Why?
|
| Intracranial Thrombosis | 4 | 2021 | 29 | 0.900 |
Why?
|
| Cohort Studies | 21 | 2024 | 2575 | 0.880 |
Why?
|
| Angioplasty | 4 | 2022 | 55 | 0.880 |
Why?
|
| Computed Tomography Angiography | 10 | 2020 | 126 | 0.880 |
Why?
|
| Sensitivity and Specificity | 23 | 2018 | 1152 | 0.880 |
Why?
|
| Angiography | 13 | 2020 | 153 | 0.880 |
Why?
|
| Exophthalmos | 3 | 2022 | 4 | 0.880 |
Why?
|
| Spinal Diseases | 4 | 2018 | 49 | 0.870 |
Why?
|
| Diagnostic Errors | 1 | 2025 | 101 | 0.870 |
Why?
|
| Thromboembolism | 5 | 2020 | 73 | 0.850 |
Why?
|
| Arteries | 4 | 2021 | 81 | 0.850 |
Why?
|
| Carotid Arteries | 4 | 2019 | 61 | 0.850 |
Why?
|
| Diagnosis, Differential | 17 | 2018 | 981 | 0.840 |
Why?
|
| Robotic Surgical Procedures | 3 | 2021 | 160 | 0.840 |
Why?
|
| Ultrasonography, Interventional | 1 | 2024 | 109 | 0.820 |
Why?
|
| Mechanical Thrombolysis | 3 | 2018 | 37 | 0.810 |
Why?
|
| Reproducibility of Results | 19 | 2025 | 1666 | 0.800 |
Why?
|
| Meninges | 1 | 2023 | 10 | 0.790 |
Why?
|
| Maxillary Artery | 1 | 2022 | 2 | 0.790 |
Why?
|
| Prospective Studies | 29 | 2025 | 3302 | 0.790 |
Why?
|
| Four-Dimensional Computed Tomography | 4 | 2019 | 5 | 0.770 |
Why?
|
| Posterior Cerebral Artery | 4 | 2023 | 13 | 0.770 |
Why?
|
| Reperfusion | 3 | 2019 | 37 | 0.760 |
Why?
|
| Polyvinyls | 2 | 2021 | 20 | 0.760 |
Why?
|
| Visual Pathways | 6 | 2006 | 20 | 0.760 |
Why?
|
| Cerebral Infarction | 7 | 2023 | 83 | 0.750 |
Why?
|
| Intraoperative Complications | 2 | 2020 | 92 | 0.750 |
Why?
|
| Jugular Veins | 4 | 2023 | 29 | 0.740 |
Why?
|
| Radial Artery | 2 | 2020 | 54 | 0.740 |
Why?
|
| Risk Factors | 20 | 2025 | 5316 | 0.730 |
Why?
|
| Cauda Equina | 2 | 2018 | 7 | 0.720 |
Why?
|
| Severity of Illness Index | 12 | 2020 | 1556 | 0.710 |
Why?
|
| Electroencephalography | 9 | 2025 | 150 | 0.710 |
Why?
|
| Betacoronavirus | 2 | 2020 | 181 | 0.710 |
Why?
|
| Pandemics | 3 | 2020 | 671 | 0.700 |
Why?
|
| Cranial Sinuses | 6 | 2022 | 12 | 0.690 |
Why?
|
| Carotid Artery, Common | 8 | 2006 | 29 | 0.690 |
Why?
|
| Algorithms | 7 | 2020 | 1005 | 0.680 |
Why?
|
| Blood Vessel Prosthesis Implantation | 5 | 2022 | 295 | 0.680 |
Why?
|
| Eye Diseases | 3 | 2016 | 36 | 0.680 |
Why?
|
| Hemodynamics | 6 | 2020 | 248 | 0.680 |
Why?
|
| Cone-Beam Computed Tomography | 4 | 2021 | 72 | 0.670 |
Why?
|
| Abnormalities, Multiple | 3 | 2018 | 54 | 0.670 |
Why?
|
| Radiography | 13 | 2021 | 552 | 0.670 |
Why?
|
| Zygapophyseal Joint | 1 | 2020 | 3 | 0.660 |
Why?
|
| Infarction | 3 | 2022 | 20 | 0.660 |
Why?
|
| Robotics | 1 | 2021 | 86 | 0.660 |
Why?
|
| Retinal Artery Occlusion | 1 | 2020 | 5 | 0.660 |
Why?
|
| Facial Nerve | 1 | 2020 | 16 | 0.650 |
Why?
|
| Neurocutaneous Syndromes | 3 | 2020 | 9 | 0.650 |
Why?
|
| MELAS Syndrome | 1 | 2019 | 1 | 0.640 |
Why?
|
| Iodine | 1 | 2019 | 19 | 0.620 |
Why?
|
| Antibodies, Monoclonal | 1 | 2023 | 863 | 0.610 |
Why?
|
| Stereotaxic Techniques | 8 | 2002 | 31 | 0.600 |
Why?
|
| Cerebral Revascularization | 4 | 2019 | 30 | 0.600 |
Why?
|
| Tissue Plasminogen Activator | 9 | 2020 | 127 | 0.600 |
Why?
|
| Inhalant Abuse | 1 | 2018 | 1 | 0.600 |
Why?
|
| Toluene | 1 | 2018 | 8 | 0.600 |
Why?
|
| Reflex, Trigeminocardiac | 1 | 2018 | 5 | 0.590 |
Why?
|
| Perioperative Care | 2 | 2019 | 85 | 0.590 |
Why?
|
| 22q11 Deletion Syndrome | 1 | 2018 | 1 | 0.580 |
Why?
|
| Tinnitus | 4 | 2025 | 19 | 0.580 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2018 | 17 | 0.580 |
Why?
|
| Gray Matter | 1 | 2018 | 36 | 0.580 |
Why?
|
| Leukoencephalopathies | 1 | 2018 | 25 | 0.580 |
Why?
|
| Brain Stem Neoplasms | 1 | 2018 | 3 | 0.580 |
Why?
|
| Spinal Cord Compression | 5 | 2012 | 30 | 0.580 |
Why?
|
| Vestibulocochlear Nerve | 1 | 2018 | 5 | 0.580 |
Why?
|
| Ophthalmoplegia | 1 | 2018 | 3 | 0.580 |
Why?
|
| Vestibulocochlear Nerve Diseases | 1 | 2018 | 3 | 0.580 |
Why?
|
| Ganglioglioma | 1 | 2018 | 3 | 0.580 |
Why?
|
| Image Interpretation, Computer-Assisted | 7 | 2019 | 180 | 0.580 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2018 | 3 | 0.580 |
Why?
|
| Face | 4 | 2018 | 36 | 0.570 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 662 | 0.570 |
Why?
|
| Transcranial Magnetic Stimulation | 7 | 2003 | 27 | 0.560 |
Why?
|
| Cerebral Hemorrhage, Traumatic | 1 | 2018 | 2 | 0.560 |
Why?
|
| Fibrinolytic Agents | 8 | 2020 | 170 | 0.560 |
Why?
|
| Constriction, Pathologic | 7 | 2025 | 128 | 0.550 |
Why?
|
| Hydrocephalus | 5 | 2014 | 43 | 0.540 |
Why?
|
| Meglumine | 2 | 2007 | 20 | 0.540 |
Why?
|
| Cerebrum | 1 | 2017 | 16 | 0.540 |
Why?
|
| Neoplasms, Neuroepithelial | 1 | 2017 | 5 | 0.540 |
Why?
|
| Predictive Value of Tests | 16 | 2025 | 1093 | 0.540 |
Why?
|
| Organometallic Compounds | 2 | 2007 | 65 | 0.530 |
Why?
|
| Infant, Newborn | 20 | 2025 | 1363 | 0.520 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2013 | 30 | 0.520 |
Why?
|
| Microsurgery | 8 | 2025 | 53 | 0.510 |
Why?
|
| Blood Flow Velocity | 4 | 2019 | 71 | 0.510 |
Why?
|
| Magnetics | 5 | 2006 | 53 | 0.510 |
Why?
|
| Regional Blood Flow | 9 | 2020 | 110 | 0.510 |
Why?
|
| Platelet Aggregation Inhibitors | 5 | 2025 | 228 | 0.510 |
Why?
|
| Actins | 1 | 2018 | 259 | 0.500 |
Why?
|
| Enbucrilate | 2 | 2013 | 9 | 0.500 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2016 | 43 | 0.500 |
Why?
|
| Bone Remodeling | 1 | 2016 | 25 | 0.490 |
Why?
|
| Catheterization | 5 | 2018 | 113 | 0.490 |
Why?
|
| Heart Arrest | 1 | 2018 | 174 | 0.490 |
Why?
|
| Lumbar Vertebrae | 6 | 2023 | 162 | 0.490 |
Why?
|
| Temporal Lobe | 4 | 2013 | 45 | 0.480 |
Why?
|
| Choroid Plexus Neoplasms | 1 | 2015 | 1 | 0.480 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 32 | 0.480 |
Why?
|
| Skull | 5 | 2025 | 49 | 0.480 |
Why?
|
| Electric Stimulation | 12 | 2003 | 139 | 0.470 |
Why?
|
| Rabbits | 12 | 2011 | 333 | 0.460 |
Why?
|
| Lipomatosis | 1 | 2015 | 8 | 0.460 |
Why?
|
| Circle of Willis | 2 | 2015 | 7 | 0.460 |
Why?
|
| Echo-Planar Imaging | 5 | 2016 | 33 | 0.460 |
Why?
|
| Genetic Association Studies | 2 | 2015 | 120 | 0.460 |
Why?
|
| Hyperemia | 2 | 2012 | 13 | 0.450 |
Why?
|
| Vascular Diseases | 1 | 2016 | 81 | 0.450 |
Why?
|
| Corpus Callosum | 2 | 2014 | 42 | 0.450 |
Why?
|
| Angioscopy | 1 | 2014 | 1 | 0.440 |
Why?
|
| Carcinoma | 1 | 2015 | 124 | 0.440 |
Why?
|
| Recurrence | 10 | 2019 | 642 | 0.440 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2019 | 775 | 0.430 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2014 | 3 | 0.430 |
Why?
|
| Temporomandibular Joint | 1 | 2014 | 2 | 0.430 |
Why?
|
| Orbit | 4 | 2022 | 16 | 0.430 |
Why?
|
| Radiographic Image Enhancement | 2 | 2015 | 98 | 0.430 |
Why?
|
| Trichinellosis | 1 | 2014 | 3 | 0.430 |
Why?
|
| Arthroscopy | 1 | 2014 | 29 | 0.430 |
Why?
|
| Thrombosis | 4 | 2021 | 199 | 0.420 |
Why?
|
| Vertebrobasilar Insufficiency | 3 | 2020 | 24 | 0.420 |
Why?
|
| Central Nervous System Cysts | 1 | 2013 | 2 | 0.420 |
Why?
|
| Neuronavigation | 4 | 2006 | 13 | 0.410 |
Why?
|
| Neovascularization, Pathologic | 5 | 2018 | 140 | 0.410 |
Why?
|
| Feasibility Studies | 7 | 2021 | 571 | 0.400 |
Why?
|
| Phantoms, Imaging | 7 | 2021 | 214 | 0.400 |
Why?
|
| Disease Progression | 7 | 2020 | 1170 | 0.400 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2013 | 18 | 0.390 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2025 | 212 | 0.380 |
Why?
|
| Radiography, Interventional | 2 | 2014 | 79 | 0.380 |
Why?
|
| Databases, Factual | 12 | 2021 | 851 | 0.380 |
Why?
|
| Visual Cortex | 5 | 2004 | 26 | 0.380 |
Why?
|
| Tomography, Emission-Computed | 2 | 2002 | 42 | 0.380 |
Why?
|
| Time Factors | 19 | 2020 | 3732 | 0.380 |
Why?
|
| Vasospasm, Intracranial | 4 | 2015 | 30 | 0.370 |
Why?
|
| Migraine Disorders | 1 | 2012 | 41 | 0.370 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2012 | 45 | 0.370 |
Why?
|
| Pons | 2 | 2020 | 15 | 0.370 |
Why?
|
| Lumbosacral Region | 4 | 2018 | 22 | 0.370 |
Why?
|
| Extracellular Fluid | 2 | 2021 | 10 | 0.360 |
Why?
|
| Artifacts | 5 | 2007 | 125 | 0.360 |
Why?
|
| Magnetic Field Therapy | 1 | 2011 | 3 | 0.350 |
Why?
|
| Myxoma | 1 | 2011 | 13 | 0.350 |
Why?
|
| Transverse Sinuses | 2 | 2021 | 6 | 0.350 |
Why?
|
| Sinus Pericranii | 2 | 2008 | 4 | 0.350 |
Why?
|
| Spinal Cord Vascular Diseases | 2 | 2010 | 2 | 0.350 |
Why?
|
| Microspheres | 1 | 2011 | 57 | 0.350 |
Why?
|
| Choroid | 1 | 2011 | 26 | 0.350 |
Why?
|
| Heart Neoplasms | 1 | 2011 | 36 | 0.350 |
Why?
|
| Neoplasms | 2 | 2020 | 1372 | 0.340 |
Why?
|
| Electrodes, Implanted | 3 | 2020 | 38 | 0.340 |
Why?
|
| Intracranial Hypotension | 2 | 2022 | 7 | 0.340 |
Why?
|
| Oxygen | 10 | 2009 | 317 | 0.340 |
Why?
|
| Hemangioma, Cavernous | 4 | 2003 | 8 | 0.340 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2017 | 86 | 0.330 |
Why?
|
| Orbital Diseases | 2 | 2022 | 10 | 0.330 |
Why?
|
| Eye Abnormalities | 2 | 2007 | 21 | 0.330 |
Why?
|
| Pattern Recognition, Automated | 1 | 2010 | 53 | 0.330 |
Why?
|
| Punctures | 4 | 2024 | 64 | 0.320 |
Why?
|
| Methanol | 1 | 2009 | 13 | 0.320 |
Why?
|
| Ischemic Attack, Transient | 2 | 2022 | 96 | 0.320 |
Why?
|
| Ethanol | 2 | 2011 | 322 | 0.320 |
Why?
|
| Syndrome | 6 | 2021 | 180 | 0.320 |
Why?
|
| Alcoholic Intoxication | 1 | 2009 | 27 | 0.320 |
Why?
|
| Multimodal Imaging | 2 | 2020 | 69 | 0.320 |
Why?
|
| Electromagnetic Fields | 2 | 2001 | 15 | 0.310 |
Why?
|
| Anterior Cerebral Artery | 2 | 2025 | 9 | 0.310 |
Why?
|
| Models, Cardiovascular | 4 | 2019 | 79 | 0.310 |
Why?
|
| Deep Brain Stimulation | 3 | 2020 | 67 | 0.310 |
Why?
|
| Phlebography | 5 | 2020 | 44 | 0.310 |
Why?
|
| Brain Injuries | 3 | 2009 | 140 | 0.310 |
Why?
|
| Cranial Nerve Diseases | 1 | 2009 | 1 | 0.310 |
Why?
|
| Hand | 5 | 2001 | 74 | 0.300 |
Why?
|
| Vasa Vasorum | 2 | 2020 | 2 | 0.300 |
Why?
|
| Thoracic Vertebrae | 3 | 2023 | 35 | 0.300 |
Why?
|
| Signal Processing, Computer-Assisted | 4 | 2002 | 98 | 0.300 |
Why?
|
| Time-to-Treatment | 3 | 2020 | 114 | 0.290 |
Why?
|
| Craniocerebral Trauma | 2 | 2008 | 55 | 0.290 |
Why?
|
| Disease Models, Animal | 12 | 2014 | 2197 | 0.280 |
Why?
|
| Head | 2 | 2021 | 54 | 0.270 |
Why?
|
| Age Factors | 9 | 2018 | 1565 | 0.270 |
Why?
|
| Radiologists | 3 | 2023 | 93 | 0.270 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2018 | 71 | 0.270 |
Why?
|
| Equipment Design | 3 | 2020 | 358 | 0.270 |
Why?
|
| Animals | 20 | 2021 | 20698 | 0.270 |
Why?
|
| Myelography | 3 | 2019 | 5 | 0.270 |
Why?
|
| Incidence | 3 | 2025 | 1380 | 0.260 |
Why?
|
| Motor Skills | 3 | 2005 | 62 | 0.260 |
Why?
|
| Music | 3 | 2005 | 80 | 0.250 |
Why?
|
| Lymphoma, B-Cell | 2 | 2011 | 61 | 0.250 |
Why?
|
| Hippocampus | 4 | 2013 | 270 | 0.250 |
Why?
|
| Synaptic Transmission | 2 | 2005 | 149 | 0.250 |
Why?
|
| Paresis | 6 | 2014 | 15 | 0.240 |
Why?
|
| Heart Defects, Congenital | 1 | 2007 | 103 | 0.240 |
Why?
|
| Dilatation, Pathologic | 3 | 2015 | 32 | 0.240 |
Why?
|
| Balloon Occlusion | 4 | 2017 | 9 | 0.240 |
Why?
|
| Functional Laterality | 8 | 2009 | 138 | 0.240 |
Why?
|
| Sinus Thrombosis, Intracranial | 2 | 2023 | 7 | 0.240 |
Why?
|
| Blindness | 1 | 2006 | 42 | 0.240 |
Why?
|
| Papilledema | 2 | 2023 | 10 | 0.240 |
Why?
|
| Intracranial Arterial Diseases | 1 | 2005 | 7 | 0.240 |
Why?
|
| Preoperative Care | 6 | 2010 | 195 | 0.240 |
Why?
|
| Diagnostic Imaging | 3 | 2021 | 265 | 0.240 |
Why?
|
| Skull Base Neoplasms | 1 | 2005 | 6 | 0.230 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2005 | 6 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 699 | 0.230 |
Why?
|
| Abducens Nerve Diseases | 1 | 2025 | 2 | 0.230 |
Why?
|
| Pilot Projects | 5 | 2015 | 1016 | 0.230 |
Why?
|
| Interneurons | 1 | 2005 | 22 | 0.230 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2004 | 6 | 0.230 |
Why?
|
| Electrophysiology | 3 | 2003 | 89 | 0.230 |
Why?
|
| Polyurethanes | 1 | 2005 | 30 | 0.230 |
Why?
|
| Foramen Magnum | 1 | 2024 | 2 | 0.230 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2025 | 82 | 0.230 |
Why?
|
| Spinal Cord Neoplasms | 3 | 2012 | 9 | 0.220 |
Why?
|
| Pancreatic Elastase | 4 | 2006 | 32 | 0.220 |
Why?
|
| Septo-Optic Dysplasia | 1 | 2004 | 2 | 0.220 |
Why?
|
| Craniofacial Abnormalities | 2 | 2020 | 22 | 0.220 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2002 | 97 | 0.220 |
Why?
|
| Motor Activity | 5 | 2003 | 346 | 0.220 |
Why?
|
| Pseudotumor Cerebri | 3 | 2019 | 10 | 0.220 |
Why?
|
| Leg | 2 | 2003 | 87 | 0.220 |
Why?
|
| Clinical Competence | 2 | 2006 | 727 | 0.220 |
Why?
|
| Movement | 5 | 2014 | 156 | 0.220 |
Why?
|
| Verbal Behavior | 3 | 2009 | 36 | 0.210 |
Why?
|
| Lumbosacral Plexus | 1 | 2003 | 6 | 0.210 |
Why?
|
| Meningocele | 1 | 2003 | 4 | 0.210 |
Why?
|
| Delphi Technique | 1 | 2024 | 101 | 0.210 |
Why?
|
| Prolapse | 1 | 2023 | 3 | 0.210 |
Why?
|
| Reference Values | 8 | 2014 | 331 | 0.210 |
Why?
|
| Sciatic Nerve | 1 | 2003 | 27 | 0.210 |
Why?
|
| Radiculopathy | 1 | 2003 | 21 | 0.210 |
Why?
|
| Multiple Trauma | 1 | 2003 | 27 | 0.210 |
Why?
|
| Case-Control Studies | 4 | 2018 | 1121 | 0.210 |
Why?
|
| Chronic Disease | 2 | 2018 | 753 | 0.210 |
Why?
|
| Olivary Nucleus | 1 | 2003 | 3 | 0.200 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2023 | 4 | 0.200 |
Why?
|
| Synapses | 1 | 2005 | 184 | 0.200 |
Why?
|
| Cerebrospinal Fluid Leak | 2 | 2022 | 14 | 0.200 |
Why?
|
| Hematoma, Subdural | 1 | 2023 | 10 | 0.200 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 3 | 2012 | 16 | 0.200 |
Why?
|
| Nerve Degeneration | 1 | 2003 | 72 | 0.200 |
Why?
|
| Sacrum | 2 | 2018 | 27 | 0.200 |
Why?
|
| Radiology | 2 | 2021 | 256 | 0.190 |
Why?
|
| Tissue Adhesives | 2 | 2013 | 8 | 0.190 |
Why?
|
| Hypertension | 3 | 2018 | 590 | 0.190 |
Why?
|
| Substance-Related Disorders | 1 | 2009 | 735 | 0.190 |
Why?
|
| Radiopharmaceuticals | 2 | 2004 | 189 | 0.180 |
Why?
|
| Teleradiology | 1 | 2021 | 3 | 0.180 |
Why?
|
| Electrodiagnosis | 1 | 2001 | 18 | 0.180 |
Why?
|
| Developmental Disabilities | 1 | 2023 | 116 | 0.180 |
Why?
|
| Age Distribution | 2 | 2013 | 259 | 0.180 |
Why?
|
| Nervous System Malformations | 1 | 2021 | 13 | 0.180 |
Why?
|
| Ultrasonography | 3 | 2018 | 485 | 0.180 |
Why?
|
| Hematoma | 2 | 2020 | 80 | 0.180 |
Why?
|
| Vascular Remodeling | 1 | 2021 | 25 | 0.180 |
Why?
|
| Models, Neurological | 2 | 2018 | 79 | 0.180 |
Why?
|
| Cyclooxygenase 2 | 1 | 2021 | 75 | 0.170 |
Why?
|
| Disease Management | 2 | 2020 | 233 | 0.170 |
Why?
|
| Coronary Angiography | 3 | 2020 | 206 | 0.170 |
Why?
|
| Arachnoid Cysts | 1 | 2001 | 6 | 0.170 |
Why?
|
| Radiation Injuries | 1 | 2021 | 67 | 0.170 |
Why?
|
| Takayasu Arteritis | 1 | 2020 | 5 | 0.170 |
Why?
|
| Mutation | 3 | 2018 | 2615 | 0.170 |
Why?
|
| Sclerotherapy | 2 | 2011 | 9 | 0.170 |
Why?
|
| Quarantine | 1 | 2020 | 11 | 0.170 |
Why?
|
| Prosthesis Design | 2 | 2015 | 224 | 0.170 |
Why?
|
| Surgical Instruments | 3 | 2011 | 43 | 0.160 |
Why?
|
| Eye | 3 | 2022 | 54 | 0.160 |
Why?
|
| Steroids | 1 | 2020 | 55 | 0.160 |
Why?
|
| Printing, Three-Dimensional | 1 | 2020 | 38 | 0.160 |
Why?
|
| Ventriculoperitoneal Shunt | 2 | 2018 | 31 | 0.160 |
Why?
|
| Epilepsies, Partial | 1 | 2000 | 18 | 0.160 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2019 | 2 | 0.160 |
Why?
|
| Prevalence | 4 | 2023 | 1387 | 0.160 |
Why?
|
| Cerebellum | 4 | 2008 | 95 | 0.160 |
Why?
|
| Hydrodynamics | 1 | 2019 | 37 | 0.160 |
Why?
|
| Propensity Score | 1 | 2020 | 160 | 0.160 |
Why?
|
| Neuroradiography | 2 | 2010 | 11 | 0.160 |
Why?
|
| Permeability | 1 | 2019 | 49 | 0.160 |
Why?
|
| Common Data Elements | 1 | 2019 | 5 | 0.160 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2015 | 59 | 0.150 |
Why?
|
| Blood Patch, Epidural | 1 | 2019 | 3 | 0.150 |
Why?
|
| Cranial Nerves | 2 | 2009 | 7 | 0.150 |
Why?
|
| Neck | 2 | 2021 | 45 | 0.150 |
Why?
|
| Thoracic Arteries | 1 | 2018 | 3 | 0.150 |
Why?
|
| Aquaporins | 1 | 2018 | 6 | 0.150 |
Why?
|
| Prosthesis Failure | 1 | 2019 | 79 | 0.150 |
Why?
|
| Intracranial Hypertension | 1 | 2018 | 10 | 0.150 |
Why?
|
| Ophthalmic Artery | 1 | 2018 | 6 | 0.140 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2018 | 17 | 0.140 |
Why?
|
| Cerebral Ventricles | 1 | 2018 | 29 | 0.140 |
Why?
|
| Fluoroscopy | 3 | 2020 | 66 | 0.140 |
Why?
|
| Postoperative Period | 2 | 2010 | 137 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2020 | 478 | 0.140 |
Why?
|
| Anticoagulants | 2 | 2021 | 495 | 0.140 |
Why?
|
| Vascular Surgical Procedures | 1 | 2020 | 255 | 0.140 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 81 | 0.140 |
Why?
|
| Vertebral Artery Dissection | 2 | 2008 | 16 | 0.140 |
Why?
|
| Analgesia, Epidural | 1 | 2018 | 27 | 0.140 |
Why?
|
| Needlestick Injuries | 1 | 2018 | 19 | 0.140 |
Why?
|
| Analgesia, Obstetrical | 1 | 2018 | 22 | 0.140 |
Why?
|
| Neuronal Plasticity | 3 | 2005 | 150 | 0.140 |
Why?
|
| Tomography, Optical Coherence | 1 | 2020 | 224 | 0.140 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2017 | 9 | 0.140 |
Why?
|
| Orbital Fractures | 1 | 2017 | 8 | 0.140 |
Why?
|
| Plant Leaves | 1 | 2017 | 39 | 0.140 |
Why?
|
| Neurologic Examination | 6 | 2013 | 53 | 0.140 |
Why?
|
| Compartment Syndromes | 1 | 2017 | 13 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 60 | 0.140 |
Why?
|
| Longitudinal Studies | 4 | 2024 | 1259 | 0.140 |
Why?
|
| Aspirin | 2 | 2025 | 172 | 0.130 |
Why?
|
| Observer Variation | 4 | 2020 | 215 | 0.130 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 2 | 2019 | 7 | 0.130 |
Why?
|
| Conus Snail | 1 | 2016 | 1 | 0.130 |
Why?
|
| Gadolinium | 1 | 2018 | 108 | 0.130 |
Why?
|
| Swine | 3 | 2014 | 389 | 0.130 |
Why?
|
| Psychomotor Performance | 4 | 2014 | 136 | 0.130 |
Why?
|
| Aneurysm, False | 1 | 2017 | 52 | 0.130 |
Why?
|
| Anisotropy | 3 | 2006 | 61 | 0.130 |
Why?
|
| Canada | 3 | 2025 | 152 | 0.130 |
Why?
|
| Neural Tube Defects | 1 | 2016 | 28 | 0.130 |
Why?
|
| Muscle, Skeletal | 5 | 2005 | 742 | 0.130 |
Why?
|
| Aicardi Syndrome | 1 | 2016 | 1 | 0.130 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2019 | 232 | 0.130 |
Why?
|
| Subtraction Technique | 2 | 2007 | 23 | 0.120 |
Why?
|
| Back Pain | 1 | 2016 | 51 | 0.120 |
Why?
|
| Patient Positioning | 2 | 2019 | 50 | 0.120 |
Why?
|
| Time and Motion Studies | 1 | 2016 | 18 | 0.120 |
Why?
|
| User-Computer Interface | 4 | 2019 | 125 | 0.120 |
Why?
|
| Evidence-Based Practice | 1 | 2017 | 84 | 0.120 |
Why?
|
| Recovery of Function | 4 | 2019 | 287 | 0.120 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2016 | 13 | 0.120 |
Why?
|
| Prosthesis Fitting | 1 | 2015 | 7 | 0.120 |
Why?
|
| Neurons | 2 | 2017 | 923 | 0.120 |
Why?
|
| Workflow | 1 | 2016 | 71 | 0.120 |
Why?
|
| Pregnancy | 6 | 2025 | 2335 | 0.120 |
Why?
|
| Internationality | 1 | 2015 | 44 | 0.120 |
Why?
|
| Sex Factors | 3 | 2021 | 974 | 0.120 |
Why?
|
| Dementia | 1 | 2018 | 262 | 0.110 |
Why?
|
| Cytarabine | 1 | 2015 | 38 | 0.110 |
Why?
|
| Fornix, Brain | 1 | 2014 | 10 | 0.110 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 49 | 0.110 |
Why?
|
| Occipital Lobe | 2 | 2013 | 17 | 0.110 |
Why?
|
| Neural Crest | 2 | 2021 | 27 | 0.110 |
Why?
|
| Fractals | 1 | 2014 | 8 | 0.110 |
Why?
|
| Phenotype | 4 | 2020 | 1207 | 0.110 |
Why?
|
| Memory Disorders | 1 | 2015 | 52 | 0.110 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2014 | 10 | 0.110 |
Why?
|
| Transposition of Great Vessels | 1 | 2014 | 2 | 0.110 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 165 | 0.110 |
Why?
|
| Evoked Potentials, Motor | 4 | 2004 | 21 | 0.110 |
Why?
|
| Patient Care Team | 2 | 2015 | 341 | 0.110 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2014 | 8 | 0.110 |
Why?
|
| Adolescent Development | 1 | 2014 | 16 | 0.110 |
Why?
|
| Methotrexate | 1 | 2015 | 80 | 0.110 |
Why?
|
| Interprofessional Relations | 1 | 2015 | 136 | 0.110 |
Why?
|
| Triiodobenzoic Acids | 2 | 2011 | 11 | 0.110 |
Why?
|
| Epidural Space | 2 | 2018 | 7 | 0.110 |
Why?
|
| Malformations of Cortical Development | 1 | 2014 | 5 | 0.110 |
Why?
|
| Pulmonary Ventilation | 1 | 2014 | 38 | 0.110 |
Why?
|
| Myocardial Contraction | 1 | 2014 | 88 | 0.110 |
Why?
|
| Ligation | 2 | 2004 | 39 | 0.100 |
Why?
|
| Retreatment | 2 | 2019 | 45 | 0.100 |
Why?
|
| DiGeorge Syndrome | 1 | 2013 | 3 | 0.100 |
Why?
|
| Ontario | 1 | 2013 | 45 | 0.100 |
Why?
|
| Neuropsychological Tests | 4 | 2024 | 393 | 0.100 |
Why?
|
| Physical Stimulation | 3 | 2005 | 30 | 0.100 |
Why?
|
| Endoscopy | 1 | 2014 | 112 | 0.100 |
Why?
|
| Spinal Nerve Roots | 2 | 2003 | 18 | 0.100 |
Why?
|
| Axons | 2 | 2006 | 123 | 0.100 |
Why?
|
| Injections, Intra-Arterial | 2 | 2011 | 21 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2013 | 254 | 0.100 |
Why?
|
| Plasmacytoma | 1 | 2012 | 9 | 0.100 |
Why?
|
| Pressure | 1 | 2013 | 79 | 0.100 |
Why?
|
| Chromosome Deletion | 2 | 2013 | 40 | 0.100 |
Why?
|
| Vertebroplasty | 1 | 2012 | 7 | 0.100 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2019 | 25 | 0.100 |
Why?
|
| Anesthesia, Conduction | 1 | 2012 | 11 | 0.100 |
Why?
|
| Bone Cements | 1 | 2012 | 17 | 0.100 |
Why?
|
| Endarterectomy, Carotid | 2 | 2010 | 84 | 0.100 |
Why?
|
| Embolism, Paradoxical | 1 | 2012 | 14 | 0.100 |
Why?
|
| Adolescent Behavior | 1 | 2014 | 194 | 0.100 |
Why?
|
| Spinal Fractures | 1 | 2012 | 36 | 0.100 |
Why?
|
| Cognition Disorders | 2 | 2018 | 217 | 0.100 |
Why?
|
| Marfan Syndrome | 1 | 2012 | 18 | 0.100 |
Why?
|
| Neurilemmoma | 1 | 2012 | 12 | 0.090 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2012 | 19 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2014 | 937 | 0.090 |
Why?
|
| Osteoporotic Fractures | 1 | 2012 | 34 | 0.090 |
Why?
|
| Iohexol | 2 | 2020 | 18 | 0.090 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2011 | 8 | 0.090 |
Why?
|
| Reaction Time | 6 | 2009 | 125 | 0.090 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2011 | 8 | 0.090 |
Why?
|
| Motor Neurons | 2 | 2005 | 212 | 0.090 |
Why?
|
| Ticlopidine | 1 | 2011 | 49 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 150 | 0.090 |
Why?
|
| Biopsy | 3 | 2012 | 446 | 0.090 |
Why?
|
| Carbon Dioxide | 1 | 2011 | 86 | 0.090 |
Why?
|
| Registries | 1 | 2015 | 879 | 0.090 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2011 | 33 | 0.090 |
Why?
|
| Morbidity | 1 | 2011 | 113 | 0.090 |
Why?
|
| Magnetite Nanoparticles | 1 | 2011 | 28 | 0.090 |
Why?
|
| Bleomycin | 1 | 2011 | 34 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2002 | 294 | 0.090 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2012 | 108 | 0.090 |
Why?
|
| Ultrasonography, Doppler, Color | 2 | 2008 | 25 | 0.090 |
Why?
|
| Respiratory-Gated Imaging Techniques | 1 | 2010 | 4 | 0.090 |
Why?
|
| Drainage, Postural | 1 | 2010 | 2 | 0.080 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2010 | 109 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 280 | 0.080 |
Why?
|
| Adhesives | 1 | 2010 | 9 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2014 | 267 | 0.080 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2010 | 33 | 0.080 |
Why?
|
| Prefrontal Cortex | 2 | 2009 | 121 | 0.080 |
Why?
|
| Reoperation | 3 | 2008 | 290 | 0.080 |
Why?
|
| Conservative Treatment | 2 | 2021 | 17 | 0.080 |
Why?
|
| Depth Perception | 2 | 2007 | 3 | 0.080 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2010 | 45 | 0.080 |
Why?
|
| Aneurysm, Infected | 1 | 2009 | 13 | 0.080 |
Why?
|
| Diplopia | 1 | 2009 | 8 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2015 | 585 | 0.080 |
Why?
|
| Posture | 1 | 2010 | 127 | 0.080 |
Why?
|
| Prenatal Diagnosis | 3 | 2021 | 40 | 0.080 |
Why?
|
| Neurology | 1 | 2010 | 41 | 0.080 |
Why?
|
| Electromyography | 3 | 2001 | 96 | 0.080 |
Why?
|
| Endothelium, Vascular | 2 | 2010 | 175 | 0.080 |
Why?
|
| Wound Healing | 2 | 2010 | 188 | 0.080 |
Why?
|
| Mental Processes | 1 | 2009 | 18 | 0.080 |
Why?
|
| Moyamoya Disease | 1 | 2009 | 12 | 0.080 |
Why?
|
| Cognition | 3 | 2022 | 484 | 0.080 |
Why?
|
| Central Nervous System Venous Angioma | 1 | 2008 | 1 | 0.070 |
Why?
|
| Software | 2 | 2010 | 388 | 0.070 |
Why?
|
| Glioblastoma | 2 | 2001 | 158 | 0.070 |
Why?
|
| Peptides | 1 | 2012 | 574 | 0.070 |
Why?
|
| Models, Anatomic | 1 | 2009 | 64 | 0.070 |
Why?
|
| Monosomy | 1 | 2008 | 2 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 23 | 0.070 |
Why?
|
| Hemangioblastoma | 1 | 2008 | 2 | 0.070 |
Why?
|
| Risk | 2 | 2022 | 378 | 0.070 |
Why?
|
| Skull Base | 1 | 2008 | 14 | 0.070 |
Why?
|
| Epidural Abscess | 1 | 2008 | 9 | 0.070 |
Why?
|
| Endoglin | 2 | 2021 | 10 | 0.070 |
Why?
|
| Rupture, Spontaneous | 3 | 2015 | 20 | 0.070 |
Why?
|
| Glasgow Coma Scale | 2 | 2007 | 46 | 0.070 |
Why?
|
| Activin Receptors, Type II | 2 | 2021 | 9 | 0.070 |
Why?
|
| Reading | 2 | 2009 | 92 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 316 | 0.070 |
Why?
|
| Schizophrenic Psychology | 1 | 2008 | 66 | 0.070 |
Why?
|
| Iatrogenic Disease | 2 | 2022 | 62 | 0.070 |
Why?
|
| Osteomyelitis | 1 | 2008 | 25 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 448 | 0.070 |
Why?
|
| Form Perception | 1 | 2007 | 5 | 0.070 |
Why?
|
| Thalamus | 1 | 2008 | 73 | 0.070 |
Why?
|
| Language | 1 | 2009 | 150 | 0.070 |
Why?
|
| Optic Neuritis | 1 | 2007 | 10 | 0.070 |
Why?
|
| Concept Formation | 1 | 2007 | 18 | 0.070 |
Why?
|
| Central Nervous System Diseases | 1 | 2008 | 57 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2007 | 172 | 0.070 |
Why?
|
| Echoencephalography | 2 | 2005 | 13 | 0.070 |
Why?
|
| Pattern Recognition, Visual | 2 | 2005 | 38 | 0.070 |
Why?
|
| Dizocilpine Maleate | 1 | 2007 | 10 | 0.070 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2008 | 129 | 0.070 |
Why?
|
| Gadolinium DTPA | 1 | 2007 | 87 | 0.070 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2007 | 37 | 0.070 |
Why?
|
| Vision Disorders | 1 | 2007 | 65 | 0.060 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2006 | 7 | 0.060 |
Why?
|
| Imagination | 2 | 2004 | 7 | 0.060 |
Why?
|
| Inflammation | 2 | 2021 | 1147 | 0.060 |
Why?
|
| Rare Diseases | 1 | 2007 | 42 | 0.060 |
Why?
|
| Age of Onset | 2 | 2019 | 174 | 0.060 |
Why?
|
| Spinal Canal | 1 | 2006 | 5 | 0.060 |
Why?
|
| Affect | 2 | 2005 | 127 | 0.060 |
Why?
|
| Hemangioma | 1 | 2006 | 28 | 0.060 |
Why?
|
| Hypertrophy | 2 | 2003 | 29 | 0.060 |
Why?
|
| Torsion Abnormality | 1 | 2006 | 12 | 0.060 |
Why?
|
| Medulla Oblongata | 1 | 2006 | 7 | 0.060 |
Why?
|
| Emphysema | 1 | 2006 | 39 | 0.060 |
Why?
|
| Infarction, Posterior Cerebral Artery | 1 | 2006 | 7 | 0.060 |
Why?
|
| Laminectomy | 3 | 2012 | 21 | 0.060 |
Why?
|
| Dissection | 2 | 2020 | 48 | 0.060 |
Why?
|
| Retinitis Pigmentosa | 1 | 2006 | 27 | 0.060 |
Why?
|
| Gliosis | 2 | 2012 | 28 | 0.060 |
Why?
|
| Schizophrenia | 1 | 2008 | 263 | 0.060 |
Why?
|
| Perception | 2 | 2004 | 175 | 0.060 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2005 | 6 | 0.060 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2005 | 60 | 0.060 |
Why?
|
| Platelet Function Tests | 1 | 2025 | 11 | 0.060 |
Why?
|
| beta-Thalassemia | 1 | 2005 | 13 | 0.060 |
Why?
|
| Subthalamic Nucleus | 1 | 2005 | 15 | 0.060 |
Why?
|
| Infusions, Intravenous | 2 | 2020 | 173 | 0.060 |
Why?
|
| Physical Fitness | 1 | 2005 | 92 | 0.060 |
Why?
|
| Hypnosis | 1 | 2004 | 3 | 0.060 |
Why?
|
| Drug Therapy | 1 | 2005 | 56 | 0.060 |
Why?
|
| Patient Care Planning | 2 | 2003 | 83 | 0.060 |
Why?
|
| Sagittal Sinus Thrombosis | 1 | 2004 | 1 | 0.060 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2004 | 2 | 0.060 |
Why?
|
| Eyelid Diseases | 1 | 2004 | 4 | 0.060 |
Why?
|
| Meningoencephalitis | 1 | 2004 | 8 | 0.060 |
Why?
|
| Pain Threshold | 1 | 2004 | 25 | 0.060 |
Why?
|
| Necrosis | 2 | 2021 | 145 | 0.060 |
Why?
|
| Edema | 1 | 2004 | 43 | 0.060 |
Why?
|
| Nerve Net | 3 | 2016 | 97 | 0.060 |
Why?
|
| Bias | 2 | 2002 | 112 | 0.050 |
Why?
|
| Parietal Lobe | 2 | 2005 | 28 | 0.050 |
Why?
|
| Brachiocephalic Trunk | 1 | 2004 | 16 | 0.050 |
Why?
|
| Arousal | 2 | 2001 | 42 | 0.050 |
Why?
|
| Acupuncture Therapy | 1 | 2004 | 19 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2004 | 132 | 0.050 |
Why?
|
| Tracheal Diseases | 1 | 2004 | 12 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 2005 | 107 | 0.050 |
Why?
|
| Attention | 2 | 2005 | 147 | 0.050 |
Why?
|
| Epidermal Cyst | 1 | 2003 | 11 | 0.050 |
Why?
|
| United States | 2 | 2019 | 7852 | 0.050 |
Why?
|
| Choristoma | 1 | 2003 | 23 | 0.050 |
Why?
|
| Elastic Tissue | 1 | 2003 | 5 | 0.050 |
Why?
|
| Esophagus | 1 | 2003 | 51 | 0.050 |
Why?
|
| Parkinson Disease | 1 | 2005 | 132 | 0.050 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 462 | 0.050 |
Why?
|
| Intraoperative Period | 4 | 2003 | 33 | 0.050 |
Why?
|
| Phosphenes | 1 | 2003 | 1 | 0.050 |
Why?
|
| Trachea | 1 | 2003 | 85 | 0.050 |
Why?
|
| Consensus | 1 | 2024 | 201 | 0.050 |
Why?
|
| Thyroid Gland | 1 | 2003 | 81 | 0.050 |
Why?
|
| Blood-Brain Barrier | 1 | 2003 | 85 | 0.050 |
Why?
|
| Eye Neoplasms | 1 | 2003 | 17 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2005 | 256 | 0.050 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2002 | 6 | 0.050 |
Why?
|
| Learning Curve | 1 | 2022 | 35 | 0.050 |
Why?
|
| Comorbidity | 1 | 2006 | 1117 | 0.050 |
Why?
|
| Monitoring, Intraoperative | 3 | 2010 | 46 | 0.050 |
Why?
|
| Putaminal Hemorrhage | 1 | 2002 | 1 | 0.050 |
Why?
|
| Astrocytoma | 2 | 2001 | 12 | 0.050 |
Why?
|
| Neurocytoma | 1 | 2002 | 1 | 0.050 |
Why?
|
| Neuroprotection | 1 | 2022 | 1 | 0.050 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2002 | 47 | 0.050 |
Why?
|
| Putamen | 1 | 2002 | 21 | 0.050 |
Why?
|
| Somatosensory Cortex | 1 | 2002 | 20 | 0.050 |
Why?
|
| Brain Abscess | 1 | 2002 | 7 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 2002 | 28 | 0.050 |
Why?
|
| Myelitis | 1 | 2001 | 4 | 0.050 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2001 | 23 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2008 | 346 | 0.040 |
Why?
|
| Borderline Personality Disorder | 1 | 2001 | 14 | 0.040 |
Why?
|
| Video-Assisted Surgery | 1 | 2001 | 10 | 0.040 |
Why?
|
| Microtomy | 1 | 2001 | 3 | 0.040 |
Why?
|
| Microscopy, Polarization | 1 | 2001 | 7 | 0.040 |
Why?
|
| Glioma | 1 | 2002 | 100 | 0.040 |
Why?
|
| Amygdala | 1 | 2001 | 83 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2001 | 30 | 0.040 |
Why?
|
| Problem Solving | 1 | 2001 | 32 | 0.040 |
Why?
|
| Single-Blind Method | 2 | 2016 | 144 | 0.040 |
Why?
|
| Photic Stimulation | 3 | 2007 | 90 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2025 | 435 | 0.040 |
Why?
|
| Drainage | 1 | 2021 | 154 | 0.040 |
Why?
|
| Lymphoma | 1 | 2001 | 104 | 0.040 |
Why?
|
| Vascular Access Devices | 1 | 2020 | 15 | 0.040 |
Why?
|
| Cysts | 1 | 2001 | 41 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2025 | 985 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2025 | 705 | 0.040 |
Why?
|
| Auditory Cortex | 1 | 2000 | 6 | 0.040 |
Why?
|
| Menstrual Cycle | 1 | 2001 | 82 | 0.040 |
Why?
|
| Spain | 1 | 2020 | 33 | 0.040 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 332 | 0.040 |
Why?
|
| Eligibility Determination | 1 | 2020 | 36 | 0.040 |
Why?
|
| Critical Care | 1 | 2004 | 397 | 0.040 |
Why?
|
| Estrogens | 1 | 2001 | 116 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 895 | 0.040 |
Why?
|
| Device Removal | 1 | 2000 | 68 | 0.040 |
Why?
|
| Germany | 2 | 2010 | 54 | 0.040 |
Why?
|
| Sturge-Weber Syndrome | 1 | 2020 | 2 | 0.040 |
Why?
|
| Paralysis | 1 | 2000 | 17 | 0.040 |
Why?
|
| Medical Errors | 1 | 2002 | 196 | 0.040 |
Why?
|
| Computers | 1 | 2019 | 49 | 0.040 |
Why?
|
| Microcirculation | 1 | 1999 | 53 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2002 | 380 | 0.040 |
Why?
|
| Blood Volume | 1 | 1999 | 41 | 0.040 |
Why?
|
| National Library of Medicine (U.S.) | 1 | 2019 | 3 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2021 | 768 | 0.040 |
Why?
|
| Speech Perception | 1 | 2000 | 79 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 1999 | 209 | 0.040 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2018 | 14 | 0.040 |
Why?
|
| Mass Screening | 1 | 2024 | 694 | 0.040 |
Why?
|
| Inpatients | 1 | 2021 | 305 | 0.040 |
Why?
|
| Lymphatic System | 1 | 2018 | 19 | 0.040 |
Why?
|
| Sclerosis | 1 | 1998 | 9 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2000 | 287 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 61 | 0.040 |
Why?
|
| California | 1 | 2018 | 174 | 0.040 |
Why?
|
| Positron-Emission Tomography | 2 | 2012 | 208 | 0.040 |
Why?
|
| Data Collection | 1 | 2000 | 384 | 0.040 |
Why?
|
| Ligamentum Flavum | 1 | 2018 | 2 | 0.040 |
Why?
|
| Mothers | 1 | 2021 | 276 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 39 | 0.030 |
Why?
|
| Exome | 1 | 2018 | 77 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2018 | 82 | 0.030 |
Why?
|
| Forearm | 1 | 1997 | 22 | 0.030 |
Why?
|
| Tongue | 1 | 1997 | 15 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 197 | 0.030 |
Why?
|
| Patient Selection | 1 | 2020 | 491 | 0.030 |
Why?
|
| Prognosis | 2 | 2014 | 1746 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 2016 | 85 | 0.030 |
Why?
|
| After-Hours Care | 1 | 2016 | 9 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2019 | 269 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 226 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2009 | 609 | 0.030 |
Why?
|
| Anesthesia, General | 1 | 2016 | 46 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 64 | 0.030 |
Why?
|
| Decompression, Surgical | 2 | 2008 | 69 | 0.030 |
Why?
|
| Aging | 1 | 2001 | 745 | 0.030 |
Why?
|
| Evoked Potentials, Visual | 2 | 2007 | 13 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 937 | 0.030 |
Why?
|
| Markov Chains | 1 | 2014 | 37 | 0.030 |
Why?
|
| Triage | 1 | 2016 | 129 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2016 | 217 | 0.030 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2014 | 2 | 0.030 |
Why?
|
| Research Design | 1 | 2018 | 575 | 0.030 |
Why?
|
| Software Validation | 1 | 2014 | 9 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2014 | 64 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 2014 | 27 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 840 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1275 | 0.030 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2014 | 6 | 0.030 |
Why?
|
| Breath Holding | 1 | 2014 | 7 | 0.030 |
Why?
|
| Intelligence Tests | 1 | 2014 | 26 | 0.030 |
Why?
|
| Semantics | 2 | 2008 | 57 | 0.030 |
Why?
|
| Iliac Artery | 1 | 2014 | 47 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2014 | 57 | 0.030 |
Why?
|
| Pain | 2 | 2009 | 407 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 1361 | 0.030 |
Why?
|
| Intelligence | 1 | 2014 | 52 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2013 | 10 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2014 | 96 | 0.030 |
Why?
|
| Quality of Life | 1 | 2001 | 1241 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2158 | 0.030 |
Why?
|
| Heart Failure | 1 | 2021 | 915 | 0.030 |
Why?
|
| Hemiplegia | 2 | 2003 | 4 | 0.020 |
Why?
|
| Environment | 1 | 2013 | 123 | 0.020 |
Why?
|
| Particle Accelerators | 1 | 2012 | 6 | 0.020 |
Why?
|
| Smoking | 1 | 2018 | 866 | 0.020 |
Why?
|
| Visual Perception | 2 | 2004 | 41 | 0.020 |
Why?
|
| Quadriplegia | 1 | 2012 | 14 | 0.020 |
Why?
|
| Smad4 Protein | 1 | 2012 | 4 | 0.020 |
Why?
|
| Apgar Score | 1 | 2012 | 11 | 0.020 |
Why?
|
| Sacrococcygeal Region | 1 | 2012 | 8 | 0.020 |
Why?
|
| Placebos | 1 | 2012 | 72 | 0.020 |
Why?
|
| Anesthesia, Epidural | 1 | 2012 | 24 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 193 | 0.020 |
Why?
|
| Injections, Spinal | 1 | 2012 | 46 | 0.020 |
Why?
|
| Dominance, Cerebral | 2 | 2003 | 33 | 0.020 |
Why?
|
| Bupivacaine | 1 | 2012 | 35 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 784 | 0.020 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2012 | 4 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 1407 | 0.020 |
Why?
|
| Cerebral Ventriculography | 1 | 2012 | 1 | 0.020 |
Why?
|
| Third Ventricle | 1 | 2012 | 3 | 0.020 |
Why?
|
| Ventriculostomy | 1 | 2012 | 5 | 0.020 |
Why?
|
| Anesthetics, Local | 1 | 2012 | 71 | 0.020 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 75 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2011 | 22 | 0.020 |
Why?
|
| Aorta | 1 | 2012 | 112 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2012 | 251 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2012 | 102 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 325 | 0.020 |
Why?
|
| Cocaine-Related Disorders | 1 | 2011 | 82 | 0.020 |
Why?
|
| Intellectual Disability | 1 | 2014 | 168 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 347 | 0.020 |
Why?
|
| Esthetics | 1 | 2011 | 19 | 0.020 |
Why?
|
| Sclerosing Solutions | 1 | 2011 | 6 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2011 | 127 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2012 | 193 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 738 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2010 | 15 | 0.020 |
Why?
|
| Platinum | 1 | 2010 | 20 | 0.020 |
Why?
|
| Constriction | 1 | 2010 | 9 | 0.020 |
Why?
|
| Pia Mater | 1 | 2010 | 2 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 172 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 337 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 418 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2011 | 189 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 429 | 0.020 |
Why?
|
| Paresthesia | 1 | 2009 | 6 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2009 | 17 | 0.020 |
Why?
|
| Association | 1 | 2009 | 1 | 0.020 |
Why?
|
| Speech Production Measurement | 1 | 2009 | 9 | 0.020 |
Why?
|
| Radioisotopes | 1 | 2009 | 24 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2010 | 172 | 0.020 |
Why?
|
| Hemorheology | 1 | 2008 | 6 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2010 | 230 | 0.020 |
Why?
|
| Nerve Compression Syndromes | 1 | 2008 | 12 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2009 | 134 | 0.020 |
Why?
|
| Karyotyping | 1 | 2008 | 47 | 0.020 |
Why?
|
| Speech | 1 | 2009 | 63 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 110 | 0.020 |
Why?
|
| Electrocoagulation | 1 | 2008 | 13 | 0.020 |
Why?
|
| Paired-Associate Learning | 1 | 2008 | 2 | 0.020 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2008 | 4 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 10850 | 0.020 |
Why?
|
| Word Association Tests | 1 | 2007 | 4 | 0.020 |
Why?
|
| Classification | 1 | 2007 | 12 | 0.020 |
Why?
|
| Karnofsky Performance Status | 1 | 2007 | 12 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2007 | 39 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 436 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 297 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 2588 | 0.020 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2006 | 1 | 0.020 |
Why?
|
| Raphe Nuclei | 1 | 2006 | 6 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2006 | 7 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2007 | 85 | 0.020 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2006 | 17 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 87 | 0.020 |
Why?
|
| Cause of Death | 1 | 2007 | 221 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2007 | 205 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2008 | 513 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2006 | 33 | 0.020 |
Why?
|
| Thoracic Injuries | 1 | 2006 | 45 | 0.020 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2005 | 7 | 0.010 |
Why?
|
| Intracranial Pressure | 1 | 2005 | 19 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 467 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2007 | 223 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 671 | 0.010 |
Why?
|
| Oxygen Radioisotopes | 1 | 2004 | 4 | 0.010 |
Why?
|
| Survival Rate | 1 | 2007 | 854 | 0.010 |
Why?
|
| Fibromuscular Dysplasia | 1 | 2004 | 5 | 0.010 |
Why?
|
| Rotation | 1 | 2004 | 22 | 0.010 |
Why?
|
| Instillation, Drug | 1 | 2004 | 3 | 0.010 |
Why?
|
| Foot | 1 | 2004 | 42 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2003 | 49 | 0.010 |
Why?
|
| Hand Strength | 1 | 2003 | 35 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 2045 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 375 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2004 | 105 | 0.010 |
Why?
|
| Learning | 1 | 2005 | 182 | 0.010 |
Why?
|
| Needles | 1 | 2004 | 68 | 0.010 |
Why?
|
| Sensory Thresholds | 1 | 2003 | 4 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 201 | 0.010 |
Why?
|
| Aphasia | 1 | 2003 | 45 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 2003 | 70 | 0.010 |
Why?
|
| Water | 1 | 2004 | 309 | 0.010 |
Why?
|
| Sural Nerve | 1 | 2002 | 2 | 0.010 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2002 | 14 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 2002 | 10 | 0.010 |
Why?
|
| Creatine | 1 | 2002 | 24 | 0.010 |
Why?
|
| Choline | 1 | 2002 | 23 | 0.010 |
Why?
|
| Protons | 1 | 2002 | 62 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2002 | 76 | 0.010 |
Why?
|
| Emergencies | 1 | 2002 | 120 | 0.010 |
Why?
|
| Equipment Failure | 1 | 2002 | 68 | 0.010 |
Why?
|
| Fingers | 1 | 2001 | 45 | 0.010 |
Why?
|
| Craniopharyngioma | 1 | 2001 | 2 | 0.010 |
Why?
|
| Verbal Learning | 1 | 2001 | 20 | 0.010 |
Why?
|
| Heparin | 1 | 2002 | 116 | 0.010 |
Why?
|
| Orientation | 1 | 2001 | 26 | 0.010 |
Why?
|
| Thumb | 1 | 2001 | 27 | 0.010 |
Why?
|
| Craniotomy | 1 | 2001 | 20 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2002 | 195 | 0.010 |
Why?
|
| Movement Disorders | 1 | 2001 | 24 | 0.010 |
Why?
|
| Mental Recall | 1 | 2001 | 93 | 0.010 |
Why?
|
| Phonetics | 1 | 2000 | 30 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2000 | 52 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2001 | 498 | 0.010 |
Why?
|
| Magnetoencephalography | 1 | 2000 | 7 | 0.010 |
Why?
|
| Muscular Atrophy | 1 | 2000 | 26 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2001 | 202 | 0.010 |
Why?
|
| Calibration | 1 | 2000 | 66 | 0.010 |
Why?
|
| Space Perception | 1 | 1999 | 19 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 2704 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 791 | 0.010 |
Why?
|
| Depression | 1 | 2005 | 908 | 0.010 |
Why?
|